Samsung Medical Center
🇰🇷South Korea
- Country
- 🇰🇷South Korea
- Ownership
- Subsidiary
- Established
- 1994-01-01
- Employees
- 501
- Market Cap
- -
Effect of Intermittent Hepatic Inflow Occlusion During Donor Hepatectomy In Living Donor Liver Transplantation
Phase 3
- Conditions
- Interventions
- First Posted Date
- 2010-07-28
- Last Posted Date
- 2010-07-28
- Lead Sponsor
- Samsung Medical Center
- Target Recruit Count
- 50
- Registration Number
- NCT01171742
- Locations
- 🇰🇷
Samsung Medical Center, Seoul, Korea, Republic of
A Randomized Phase II Study of Concurrent Chemoradiation With Every 3 Week of Cisplatin vs With Weekly Cisplatin in Locally Advanced Nasopharyngeal Carcinoma
Phase 2
- Conditions
- Interventions
- First Posted Date
- 2010-07-28
- Last Posted Date
- 2010-07-28
- Lead Sponsor
- Samsung Medical Center
- Target Recruit Count
- 110
- Registration Number
- NCT01171781
- Locations
- 🇰🇷
Samsung Medical Center, Seoul, Korea, Republic of
Phase II Study of Gemcitabine and TS-1 in Biliary Trat Cancer
- First Posted Date
- 2010-07-28
- Last Posted Date
- 2014-05-21
- Lead Sponsor
- Samsung Medical Center
- Target Recruit Count
- 19
- Registration Number
- NCT01171755
The Expression of Serum Angiogenesis Marker in Patients Presenting With Hemoptysis
Completed
- Conditions
- First Posted Date
- 2010-07-28
- Last Posted Date
- 2011-07-21
- Lead Sponsor
- Samsung Medical Center
- Target Recruit Count
- 52
- Registration Number
- NCT01171768
- Locations
- 🇰🇷
Samsung Medical Center, Seoul, Korea, Republic of
Efficacy of Bispectral Index Monitoring for Midazolam and Meperidine Induced Sedation During Endoscopic Submucosal Dissection
- First Posted Date
- 2010-07-07
- Last Posted Date
- 2010-07-07
- Lead Sponsor
- Samsung Medical Center
- Target Recruit Count
- 56
- Registration Number
- NCT01157598
- Locations
- 🇰🇷
Samsung Medical Center, Seoul, Korea, Republic of
The Effect of Online Based Mentoring Program on the Blood Glucose and Satisfaction Score in Type 1 Diabetes Patients
- First Posted Date
- 2010-07-07
- Last Posted Date
- 2015-11-17
- Lead Sponsor
- Samsung Medical Center
- Target Recruit Count
- 57
- Registration Number
- NCT01157611
- Locations
- 🇰🇷
Samsung Medical Center, Seoul, Korea, Republic of
Gemcitabine/Oxaliplatin (GEMOX) With or Without Erlotinib (Tarceva) in Advanced Biliary Tract Carcinoma
Phase 3
Completed
- Conditions
- Interventions
- First Posted Date
- 2010-06-23
- Last Posted Date
- 2014-05-15
- Lead Sponsor
- Samsung Medical Center
- Target Recruit Count
- 266
- Registration Number
- NCT01149122
- Locations
- 🇰🇷
Samsung Medical Center, Seoul, Korea, Republic of
Extent of Central Lymph Node Dissection in Papillary Thyroid Microcarcinoma
- First Posted Date
- 2010-06-23
- Last Posted Date
- 2016-04-21
- Lead Sponsor
- Samsung Medical Center
- Target Recruit Count
- 2000
- Registration Number
- NCT01149161
- Locations
- 🇰🇷
Samsung Medical Center, Seoul, Korea, Republic of
Aromatase (CYP19) Polymorphism Between AI-responsive and AI-resistant Breast Cancer in Korea
Suspended
- Conditions
- First Posted Date
- 2010-06-04
- Last Posted Date
- 2014-04-21
- Lead Sponsor
- Samsung Medical Center
- Target Recruit Count
- 300
- Registration Number
- NCT01137136
- Locations
- 🇰🇷
Samsung Medical Center, Seoul, Korea, Republic of
Lateral Neck Sentinel Lymph Node Biopsy(LSLNB)in PTC
Phase 2
Completed
- Conditions
- Interventions
- First Posted Date
- 2010-06-04
- Last Posted Date
- 2016-04-21
- Lead Sponsor
- Samsung Medical Center
- Target Recruit Count
- 278
- Registration Number
- NCT01137097
- Locations
- 🇰🇷
Samsung Medical Center, Seoul, Korea, Republic of
© Copyright 2024. All Rights Reserved by MedPath